Suchergebnisse - "COVID"

PubPharm (9)

1

Tocilizumab in COVID-19 management : addressing time of starting treatment

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Khiali, S. | Entezari-Maleki, T.

2

Letter to the editor : additional evidence to support a cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay

enthalten in: Journal of clinical pathology | 2022

von Cipitelli, M. | Dornelas-Ribeiro, M. | Santos, C.

3

Unexpected SARS-CoV-2 positivity in postmortem nasopharyngeal swabs

enthalten in: Journal of clinical pathology | 2022

von Jensen, M. | Wahab, L.

4

Persistent viral infectivity after 27 days from COVID-19 symptoms onset

enthalten in: Journal of clinical pathology | 2022

von Zupin, L. | Fontana, F. | Clemente, L. | +3

5

Social distancing measures for COVID-19 are changing winter season

enthalten in: Archives of disease in childhood | 2021

von Amaddeo, A. | Cason, C. | Cozzi, G. | +2

6

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients

enthalten in: Microbiology spectrum | 2021

von Walker, G. | Davis, R. | Naing, Z. | +4

7

COVID-19 resources through Friends of Millbank website

enthalten in: BMJ military health | 2021

von Vassallo, D.

CommentOn: BMJ Mil Health. 2020 Dec;166(6):440. - PMID 32753536

8

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19

enthalten in: Journal of clinical microbiology | 2020

von Rhoads, D. | Cherian, S. | Roman, K. | +3

9

Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges

enthalten in: Journal of clinical microbiology | 2020

von Broder, K. | Babiker, A. | Myers, C. | +6

1
[1]